Effect of Zoledronic Acid on Reducing Femoral Bone Mineral Density Loss following Total Hip Arthroplasty Preliminary Results of a Prospective Randomized Trial

被引：29
作者：
Scott, David F. [1 ]
Woltz, Jennifer N. [1 ]
Smith, Rachel R. [1 ]
机构：
[1] Spokane Joint Replacement Ctr Inc, Spokane, WA 99218 USA
来源：
JOURNAL OF ARTHROPLASTY | 2013年 / 28卷 / 04期
关键词：
total hip arthroplasty; bone mineral density; bisphosphonates; X-RAY ABSORPTIOMETRY; PARTICLE-INDUCED OSTEOLYSIS; DOUBLE-BLIND; IMPLANT MIGRATION; ALENDRONATE; PAMIDRONATE; BISPHOSPHONATES; PREVENTION; RESORPTION;
D O I：
10.1016/j.arth.2012.08.007
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
This randomized trial evaluated the effect of zoledronic acid on femoral bone mineral density (BMD) following primary total hip arthroplasty. Bone mineral density was compared for up to 2 years in 27 patients receiving 5 mg zoledronic acid intravenous infusion and in 24 patients receiving placebo at 2 weeks and 1 year after surgery. Zoledronic acid prevented loss of bone mineral density at 1 year (+13.8% vs +1.4%, P=.0065) and 2years (+14.3% vs -4.0%, P<.0001) in Gruen zone 1, at 1 year (-8.4% vs -25.4%, P<.0001) and 2years (-9.6% vs -27.3%, P<.0001) in Gruen zone 7, at 6weeks, 6 months, and 1 or 2 years in Gruen zones 4 and 6. For all Gruen zones, prevention of BMD loss by ZOL was significant at 6weeks, 6 months, 1 year (+0.80% vs -6.03%, P<.0001) and 2years (-0.16% vs -7.13%, P<.0001). (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：671 / 675
页数：5
相关论文
共 50 条
  • [21] Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: A randomized, double blind, controlled trial
    Samo K. Fokter
    Radko Komadina
    Alenka Repše-Fokter
    Wiener klinische Wochenschrift, 2006, 118 : 23 - 28
  • [22] Effect of etidronate in preventing periprosthetic bone loss following cemented hip arthroplasty: A randomized, double blind, controlled trial
    Fokter, Samo K.
    Komadina, Radko
    Repse-Fokter, Alenka
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (9-10) : 23 - 28
  • [23] The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: A randomized clinical trial
    Cao, Guorui
    Huang, Zeyu
    Xie, Jinwei
    Huang, Qiang
    Xu, Bin
    Zhang, ShaoYun
    Pei, FuXing
    THROMBOSIS RESEARCH, 2018, 164 : 48 - 53
  • [24] Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials
    Li, Xiao
    Han, Jingru
    Shi, Xiaotong
    Bi, Zhiguo
    Liu, Jianguo
    ARCHIVES OF OSTEOPOROSIS, 2023, 18 (01)
  • [25] Effect of pamidronate in preventing local bone loss after total hip arthroplasty: A randomized, double-blind, controlled trial
    Wilkinson, JM
    Stockley, I
    Peel, NFA
    Hamer, AJ
    Elson, RA
    Barrington, NA
    Eastell, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (03) : 556 - 564
  • [26] Effect of implant composition on periprosthetic bone mineral density after total hip arthroplasty
    Akira Morita
    Naomi Kobayashi
    Hyonmin Choe
    Taro Tezuka
    Toshihiro Misumi
    Yutaka Inaba
    Archives of Orthopaedic and Trauma Surgery, 2023, 143 : 2763 - 2771
  • [27] The influence of stem alignment on the bone mineral density around the Polarstem following total hip arthroplasty
    Fujita, Masahiro
    Hayashi, Shinya
    Hashimoto, Shingo
    Kuroda, Yuichi
    Kuroda, Ryosuke
    Matsumoto, Tomoyuki
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2023, 143 (06) : 3621 - 3627
  • [28] Effect of implant composition on periprosthetic bone mineral density after total hip arthroplasty
    Morita, Akira
    Kobayashi, Naomi
    Choe, Hyonmin
    Tezuka, Taro
    Misumi, Toshihiro
    Inaba, Yutaka
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2023, 143 (05) : 2763 - 2771
  • [29] The influence of stem alignment on the bone mineral density around the Polarstem following total hip arthroplasty
    Masahiro Fujita
    Shinya Hayashi
    Shingo Hashimoto
    Yuichi Kuroda
    Ryosuke Kuroda
    Tomoyuki Matsumoto
    Archives of Orthopaedic and Trauma Surgery, 2023, 143 : 3621 - 3627
  • [30] A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
    Lang, Joshua M.
    Wallace, Marianne
    Becker, Jordan T.
    Eickhoff, Jens C.
    Buehring, Bjoern
    Binkley, Neil
    Staab, Mary Jane
    Wilding, George
    Liu, Glenn
    Malkovsky, Miroslav
    McNeel, Douglas G.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 407 - 415
12345